Mariner Investment Group’s AstraZeneca AZN Stock Holding History

Mariner Investment Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,750	Closed	-$770K	–	88
2016 Q2	$770K	Buy	+12,750	New	+$741K	0.26%	87
2015 Q4	–	Sell	-15,000	Closed	-$955K	–	202
2015 Q3	$955K	Sell	15,000 -4,000	-21%	-$263K	0.19%	123
2015 Q2	$1.21M	Hold	19,000	–	–	0.31%	100
2015 Q1	$1.3M	Sell	19,000 -7,400	-28%	-$514K	0.35%	85
2014 Q4	$1.86M	Buy	+26,400	New	+$1.89M	0.32%	83

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Mariner Investment Group's AZN Position: Q3 2016 in Review

Mariner Investment Group sold out of AstraZeneca (AZN) in Q3 2016, closing a stake of 12,750 shares — an estimated $770K sold.

Mariner Investment Group first reported a position in AZN in Q4 2014 and held it in 5 quarters. The position peaked at $1.86M in Q4 2014. 451 funds tracked by Wall St. Rank hold AZN as of Q3 2016.

Mariner Investment Group reported no remaining AstraZeneca position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 12,750 AstraZeneca shares in Q3 2016, an estimated $770K.
Mariner Investment Group first reported a position in AstraZeneca in Q4 2014 and held it in 5 quarters.
Mariner Investment Group's AstraZeneca position peaked at $1.86M in Q4 2014.
451 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.